Eagle Health Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Eagle Health Investments’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-406,525	Closed	-$8.2M	–	29
2021 Q3	$8.2M	Buy	406,525 +245,400	+152%	+$6.78M	2.6%	19
2021 Q2	$6.01M	Hold	161,125	–	–	2.06%	18
2021 Q1	$4.12M	Buy	161,125 +92,125	+134%	+$2.35M	1.62%	23
2020 Q4	$1.52M	Buy	+69,000	New	+$1.52M	0.97%	22

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Eagle Health Investments's DRNA Position: Q4 2021 in Review

Eagle Health Investments sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 406,525 shares — an estimated $8.2M sold.

Eagle Health Investments first reported a position in DRNA in Q4 2020 and held it in 4 quarters. The position peaked at $8.2M in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Eagle Health Investments reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Eagle Health Investments sold 406,525 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $8.2M.
Eagle Health Investments first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2020 and held it in 4 quarters.
Eagle Health Investments's Dicerna Pharmaceuticals, Inc. position peaked at $8.2M in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Eagle Health Investments's 13F filing for Q4 2021, filed 10 Feb 2022.